PACER ADVISORS, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
PACER ADVISORS, INC. portfolio value:
$180.94M
portfolio value
PACER ADVISORS, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +19.03% | 41.98K shares | 50.49M | $688.87 | 262.66K |
| Q2 2022 | share | Increase | +76.02% | 95.31K shares | 42.89M | $591.13 | 220.67K |
| Q1 2022 | share | Increase | +155.78% | 76.35K shares | 56.60M | $698.42 | 125.36K |
| Q4 2021 | share | Increase | +384.99% | 38.90K shares | 24.83M | $642.51 | 49.01K |
| Q3 2021 | share | Decrease | -4.38% | -463 shares | 213K | $605.18 | 10.10K |
| Q2 2021 | share | Increase | +4.80% | 484 shares | 1.13M | $558.54 | 10.56K |
| Q1 2021 | share | Decrease | -4.96% | -526 shares | -354K | $473.14 | 10.08K |
| Q4 2020 | share | Decrease | -32.96% | -5.21K shares | -3.73M | $483.11 | 10.61K |
| Q3 2020 | share | Decrease | -8.95% | -1.55K shares | -1.98M | $559.78 | 15.82K |
| Q2 2020 | share | Increase | +98.46% | 8.62K shares | 5.85M | $623.65 | 17.38K |
| Q1 2020 | share | Increase | +3.02% | 257 shares | 1.79M | $488.29 | 8.76K |
| Q4 2019 | share | Decrease | -71.35% | -21.17K shares | -5.03M | $375.48 | 8.50K |
| Q3 2019 | share | Increase | +9.02% | 2.45K shares | -288K | $277.4 | 29.67K |
| Q2 2019 | share | Increase | +108.97% | 14.19K shares | 3.17M | $313 | 27.22K |
| Q1 2019 | share | Increase | 0.00% | 13.02K shares | 5.34M | $410.62 | 13.02K |
| Q3 2018 | share | Increase | +28.47% | 2.00K shares | 1.22M | $404.04 | 9.03K |
| Q2 2018 | share | Increase | +21.78% | 1.25K shares | 438K | $344.99 | 7.03K |
| Q1 2018 | share | Increase | +17.83% | 874 shares | 146K | $344.36 | 5.77K |
| Q4 2017 | share | Increase | +44.76% | 1.51K shares | 329K | $375.96 | 4.90K |
| Q3 2017 | share | Increase | +14.70% | 434 shares | 64K | $447.12 | 3.38K |
| Q2 2017 | share | Increase | +13.97% | 362 shares | 446K | $491.14 | 2.95K |
| Q1 2017 | share | Increase | +4.94% | 122 shares | 98K | $387.51 | 2.59K |
| Q4 2016 | share | Decrease | -1.98% | -50 shares | -107K | $367.09 | 2.46K |
| Q3 2016 | share | Decrease | -3.96% | -104 shares | 97K | $402.02 | 2.51K |
| Q2 2016 | share | Decrease | -2.45% | -66 shares | -54K | $349.23 | 2.62K |
| Q1 2016 | share | Increase | +3.82% | 99 shares | -436K | $360.44 | 2.68K |